We are live on ! Find out more
OCMI

Oaktop Capital Management II Portfolio holdings

AUM $1.34B
1-Year Est. Return 114.5%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+114.5%
3 Year Est. Return
+223.73%
5 Year Est. Return
+264.71%
10 Year Est. Return
+1,370.55%
AUM
$456M
AUM Growth
-$21.1M
Cap. Flow
-$7.66M
Cap. Flow %
-1.68%
Top 10 Hldgs %
93.65%
Holding
18
New
Increased
1
Reduced
1
Closed

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$770K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$8.43M

Sector Composition

Rank Sector Weight
1 Technology 46.69%
2 Healthcare 40.63%
3 Industrials 1.61%
4 Consumer Discretionary 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$164M 35.93%
2,064,800
-101,559
-5% -$8.43M
LRCX icon
2
Lam Research
LRCX
$382B
$52.5M 11.5%
3,035,040
+40,000
+1% +$770K
MXIM
3
DELISTED
Maxim Integrated Products
MXIM
$42.1M 9.22%
717,375
KLAC icon
4
KLA
KLAC
$275B
$41.1M 9%
4,007,500
EGAN icon
5
eGain
EGAN
$176M
$38.3M 8.39%
2,536,843
PRGS icon
6
Progress Software
PRGS
$1.55B
$23.8M 5.21%
612,526
CEVA icon
7
CEVA Inc
CEVA
$1.01B
$22.5M 4.92%
743,836
PETS icon
8
PetMed Express
PETS
$42.5M
$16.5M 3.61%
373,675
VMW
9
DELISTED
VMware, Inc
VMW
$13.6M 2.98%
92,500
AMBR
10
DELISTED
Amber Road Inc
AMBR
$13.2M 2.88%
1,398,791
XLE icon
11
State Street Energy Select Sector SPDR ETF
XLE
$39.7B
$7.59M 1.66%
200,000
ASPN icon
12
Aspen Aerogels
ASPN
$387M
$7.34M 1.61%
1,499,001
DELL icon
13
Dell
DELL
$283B
$6.58M 1.44%
277,352
AXDX
14
DELISTED
Accelerate Diagnostics
AXDX
$3.46M 0.76%
15,500
INTC icon
15
Intel
INTC
$466B
$1.64M 0.36%
33,010
NTRP
16
DELISTED
Neurotrope, Inc. Common
NTRP
$1.13M 0.25%
116,845
BBBY
17
Bed Bath & Beyond
BBBY
$473M
$830K 0.18%
32,825
ANIK icon
18
Anika Therapeutics
ANIK
$199M
$400K 0.09%
12,500

Similar funds

Oaktop Capital Management II's Q2 2018 Portfolio in Review

As of Q2 2018, Oaktop Capital Management II held 18 positions worth $456M, down 4.4% from $477M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 0%. Oaktop Capital Management II opened no new positions and made no exits, leaving the 18-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 43% a quarter earlier, followed by Healthcare and Industrials.

  • Oaktop Capital Management II added most to Lam Research in Q2 2018, an estimated $770K increase.
  • Oaktop Capital Management II's biggest Q2 2018 reduction was Celgene Corp, cutting an estimated $8.43M.
  • Oaktop Capital Management II's ten largest holdings make up 94% of its $456M portfolio in Q2 2018.
  • Oaktop Capital Management II opened 0 new positions and closed 0 in Q2 2018.
  • Oaktop Capital Management II's portfolio value fell 4.4% quarter-over-quarter to $456M.

Based on Oaktop Capital Management II's 13F filing for Q2 2018, filed 20 Jul 2018.